NCT06541080View on ClinicalTrials.gov

Collection of Liquid Biopsy Samples of Neuroendocrine Neoplasms (NEN) Patients - Collection of NET (CollectNET) 2.0, a Study by the BE-FORCE Consortium

RecruitingOBSERVATIONAL
Enrollment

550

Participants

Timeline

Start Date

January 3, 2022

Primary Completion Date

December 4, 2028

Study Completion Date

December 4, 2030

Conditions
Neuroendocrine Neoplasms
Interventions
DIAGNOSTIC_TEST

Shallow Whole Genome Sequencing (sWGS)-GIPXplore

GIPXplore will be used to mine shallow whole genome sequencing cell free DNA data for identification of signatures.

DIAGNOSTIC_TEST

methylation-sensitive restriction enzymes (MSRE)-Single-molecule molecular inversion probes (smMIP)-seq assay

Aberrant methylation in ccfDNA will be analyzed using the novel, highly sensitive MSRE-smMIP-seq technology.

Trial Locations (8)

2020

NOT_YET_RECRUITING

Ziekenhuis Netwerk Antwerpen (ZNA), Antwerp

2610

NOT_YET_RECRUITING

Gasthuiszusters Ziekenhuizen (GZA), Antwerp

2650

RECRUITING

Antwerp University Hospital (UZA), Edegem

2930

NOT_YET_RECRUITING

AZ Klina, Brasschaat

Unknown

NOT_YET_RECRUITING

AZ Rivierenland, Rumst

NOT_YET_RECRUITING

VITAZ, Sint-Niklaas

NOT_YET_RECRUITING

University Hospital Leuven, Leuven

NOT_YET_RECRUITING

AZ Monica, Antwerp

All Listed Sponsors
collaborator

Universitaire Ziekenhuizen KU Leuven

OTHER

collaborator

Universiteit Antwerpen

OTHER

collaborator

KU Leuven

OTHER

lead

University Hospital, Antwerp

OTHER